Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive79

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive14

Views

Views
November 20251
December 20250
January 20260
February 20260
March 20260
April 202612
May 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil1
Canada1
Germany1
France1
United Kingdom1
Mexico1
 

Top cities views

Views
Culiacán1
Frankfurt am Main1
Glasgow1
Newark1
Secaucus1
São Paulo1